相似文献
1
Geroneuroprotectors: Effective Geroprotectors for the Brain.
Trends Pharmacol Sci. 2018 Dec;39(12):1004-1007. doi: 10.1016/j.tips.2018.09.008. Epub 2018 Nov 13.
2
Resveratrol as a Natural Autophagy Regulator for Prevention and Treatment of Alzheimer's Disease.
Nutrients. 2017 Aug 24;9(9):927. doi: 10.3390/nu9090927.
3
Multi-target, neuroprotective and neurorestorative M30 improves cognitive impairment and reduces Alzheimer's-like neuropathology and age-related alterations in mice.
Mol Neurobiol. 2012 Aug;46(1):217-20. doi: 10.1007/s12035-012-8304-7. Epub 2012 Jul 31.
4
Selecting for neurogenic potential as an alternative for Alzheimer's disease drug discovery.
Alzheimers Dement. 2016 Jun;12(6):678-86. doi: 10.1016/j.jalz.2016.03.016. Epub 2016 May 2.
5
Nerve growth factor in treatment and pathogenesis of Alzheimer's disease.
Prog Neurobiol. 2006 Oct;80(3):114-28. doi: 10.1016/j.pneurobio.2006.09.001. Epub 2006 Nov 2.
6
An alternative approach to drug discovery for Alzheimer's disease dementia.
Future Med Chem. 2012 Sep;4(13):1681-8. doi: 10.4155/fmc.12.109.
7
Empirical evidence of neuroprotection by dual cholinesterase inhibition in Alzheimer's disease.
Neuroreport. 2005 Feb 8;16(2):107-10. doi: 10.1097/00001756-200502080-00006.
8
Discovery of novel rivastigmine-hydroxycinnamic acid hybrids as multi-targeted agents for Alzheimer's disease.
Eur J Med Chem. 2017 Jan 5;125:784-792. doi: 10.1016/j.ejmech.2016.09.052. Epub 2016 Sep 17.
9
Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
Neuropharmacology. 2014 Jan;76 Pt A:57-67. doi: 10.1016/j.neuropharm.2013.08.005. Epub 2013 Aug 21.
10
Microglia-Based Phenotypic Screening Identifies a Novel Inhibitor of Neuroinflammation Effective in Alzheimer's Disease Models.
ACS Chem Neurosci. 2016 Nov 16;7(11):1499-1507. doi: 10.1021/acschemneuro.6b00125. Epub 2016 Sep 2.
引用本文的文献
1
Geroscience and Alzheimer's Disease Drug Development.
J Prev Alzheimers Dis. 2023;10(4):620-632. doi: 10.14283/jpad.2023.103.
2
Proteostasis is differentially modulated by inhibition of translation initiation or elongation.
Elife. 2023 Oct 5;12:e76465. doi: 10.7554/eLife.76465.
3
The Role of AMP-activated Protein Kinase in Oxytosis/Ferroptosis: Protector or Potentiator?
Antioxid Redox Signal. 2024 Dec;41(16-18):e1173-e1186. doi: 10.1089/ars.2022.0013. Epub 2022 Apr 8.
4
The Alzheimer's disease drug candidate J147 decreases blood plasma fatty acid levels via modulation of AMPK/ACC1 signaling in the liver.
Biomed Pharmacother. 2022 Mar;147:112648. doi: 10.1016/j.biopha.2022.112648. Epub 2022 Jan 17.
5
Cannabinol inhibits oxytosis/ferroptosis by directly targeting mitochondria independently of cannabinoid receptors.
Free Radic Biol Med. 2022 Feb 20;180:33-51. doi: 10.1016/j.freeradbiomed.2022.01.001. Epub 2022 Jan 6.
6
Deep Modeling of Regulating Effects of Small Molecules on Longevity-Associated Genes.
Pharmaceuticals (Basel). 2021 Sep 22;14(10):948. doi: 10.3390/ph14100948.
7
extract attenuates staurosporine induced neurotoxicity by restoring the FGF2-PI3K/Akt signaling axis and Dnmt3.
Heliyon. 2021 Jul 7;7(7):e07503. doi: 10.1016/j.heliyon.2021.e07503. eCollection 2021 Jul.
8
Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer's Disease.
Neuropsychiatr Dis Treat. 2021 May 4;17:1311-1339. doi: 10.2147/NDT.S264910. eCollection 2021.
9
The search for anti-oxytotic/ferroptotic compounds in the plant world.
Br J Pharmacol. 2021 Sep;178(18):3611-3626. doi: 10.1111/bph.15517. Epub 2021 Jun 6.
10
Treatment with Bacterial Biologics Promotes Healthy Aging and Traumatic Brain Injury Responses in Adult Modeling the Gut-Brain Axis and Inflammation Responses.
Cells. 2021 Apr 14;10(4):900. doi: 10.3390/cells10040900.
本文引用的文献
1
The mitochondrial ATP synthase is a shared drug target for aging and dementia.
Aging Cell. 2018 Apr;17(2). doi: 10.1111/acel.12715. Epub 2018 Jan 7.
2
A novel Alzheimer's disease drug candidate targeting inflammation and fatty acid metabolism.
Alzheimers Res Ther. 2017 Jul 14;9(1):50. doi: 10.1186/s13195-017-0277-3.
3
Fisetin Reduces the Impact of Aging on Behavior and Physiology in the Rapidly Aging SAMP8 Mouse.
J Gerontol A Biol Sci Med Sci. 2018 Mar 2;73(3):299-307. doi: 10.1093/gerona/glx104.
4
Selecting for neurogenic potential as an alternative for Alzheimer's disease drug discovery.
Alzheimers Dement. 2016 Jun;12(6):678-86. doi: 10.1016/j.jalz.2016.03.016. Epub 2016 May 2.
5
Calorie restriction as an intervention in ageing.
J Physiol. 2016 Apr 15;594(8):2043-60. doi: 10.1113/JP270543. Epub 2016 Jan 3.
6
A comprehensive multiomics approach toward understanding the relationship between aging and dementia.
Aging (Albany NY). 2015 Nov;7(11):937-55. doi: 10.18632/aging.100838.
7
Geroprotectors.org: a new, structured and curated database of current therapeutic interventions in aging and age-related disease.
Aging (Albany NY). 2015 Sep;7(9):616-28. doi: 10.18632/aging.100799.
8
Clinical development of curcumin in neurodegenerative disease.
Expert Rev Neurother. 2015 Jun;15(6):629-37. doi: 10.1586/14737175.2015.1044981.
9
How fisetin reduces the impact of age and disease on CNS function.
Front Biosci (Schol Ed). 2015 Jun 1;7(1):58-82. doi: 10.2741/S425.
10
Back to the future with phenotypic screening.
ACS Chem Neurosci. 2014 Jul 16;5(7):503-13. doi: 10.1021/cn500051h. Epub 2014 Jun 5.
Zotero 插件